Co-Authors
This is a "connection" page, showing publications co-authored by Stanley Xu and Jason Glanz.
Connection Strength
9.793
-
An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data. Pharmacoepidemiol Drug Saf. 2023 Oct 10.
Score: 0.922
-
Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study. Pharmacoepidemiol Drug Saf. 2021 Sep; 30(9):1200-1213.
Score: 0.783
-
Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy. JAMA Netw Open. 2019 Apr 05; 2(4):e192613.
Score: 0.674
-
Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule. Vaccine. 2019 Feb 28; 37(10):1325-1331.
Score: 0.666
-
Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample. Biom J. 2018 07; 60(4):748-760.
Score: 0.634
-
Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25.
Score: 0.469
-
A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013 Aug 30; 32(19):3290-9.
Score: 0.438
-
Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies. J Biom Biostat. 2012 Apr 19; Suppl 7:006.
Score: 0.416
-
Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011 Mar 30; 30(7):742-52.
Score: 0.378
-
Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial. BMJ Public Health. 2024 Jul; 2(1).
Score: 0.243
-
Mortality risk after COVID-19 vaccination: A self-controlled case series study. Vaccine. 2024 Mar 07; 42(7):1731-1737.
Score: 0.236
-
Impact of the COVID-19 Pandemic on Health Care Utilization in the Vaccine Safety Datalink: Retrospective Cohort Study. JMIR Public Health Surveill. 2024 Jan 23; 10:e48159.
Score: 0.235
-
Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy. Subst Abus. 2023 07; 44(3):209-219.
Score: 0.229
-
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. Vaccine. 2023 01 16; 41(3):844-854.
Score: 0.218
-
Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment. JAMA Netw Open. 2022 10 03; 5(10):e2234671.
Score: 0.215
-
The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatment. Addiction. 2022 Jul 11.
Score: 0.211
-
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic. Vaccine. 2022 05 20; 40(23):3150-3158.
Score: 0.208
-
Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic Trial. J Gen Intern Med. 2022 Feb 07.
Score: 0.205
-
The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 2021 12 01; 148(6).
Score: 0.203
-
COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 29; 70(43):1520-1524.
Score: 0.201
-
Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. JAMA Pediatr. 2020 05 01; 174(5):455-462.
Score: 0.182
-
Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age. Pediatr Infect Dis J. 2020 03; 39(3):247-253.
Score: 0.179
-
A primer on quantitative bias analysis with positive predictive values in research using electronic health data. J Am Med Inform Assoc. 2019 12 01; 26(12):1664-1674.
Score: 0.176
-
Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 Oct; 33(10):1646-1653.
Score: 0.155
-
Bias from outcome misclassification in immunization schedule safety research. Pharmacoepidemiol Drug Saf. 2018 Feb; 27(2):221-228.
Score: 0.155
-
Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial. Pediatrics. 2017 Dec; 140(6).
Score: 0.153
-
Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol. 2013 Dec 15; 178(12):1750-9.
Score: 0.115
-
A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013 Mar 01; 167(3):274-81.
Score: 0.110
-
An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 2012 Jun 08; 30(27):3986-91.
Score: 0.104
-
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):749-55.
Score: 0.099
-
A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008 Mar; 121(3):e506-12.
Score: 0.078
-
Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006 Aug; 59(8):808-18.
Score: 0.068
-
COVID-19 Vaccination Coverage and Factors Associated With Vaccine Uptake Among People With HIV. JAMA Netw Open. 2024 Jun 03; 7(6):e2415220.
Score: 0.060
-
Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink. Vaccine. 2023 07 19; 41(32):4658-4665.
Score: 0.056
-
Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis. J Gen Intern Med. 2023 Jan 25.
Score: 0.055
-
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Sep 03.
Score: 0.050
-
The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study. Drug Alcohol Depend. 2020 12 01; 217:108248.
Score: 0.046
-
The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2018 Jan; 27(1):59-68.
Score: 0.038
-
Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9.
Score: 0.030
-
Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics. 2012 Jan; 129(1):e54-9.
Score: 0.025
-
Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008 Jun 19; 26(26):3341-5.
Score: 0.020
-
Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008 Mar; 121(3):e687-92.
Score: 0.020
-
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006 Oct 25; 296(16):1990-7.
Score: 0.018
-
Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med. 2004 Nov; 158(11):1031-6.
Score: 0.016